178 related articles for article (PubMed ID: 18776971)
1. Regression of atherosclerosis demands low LDL targets and raised HDL levels.
Cardiovasc J Afr; 2008; 19(4):221. PubMed ID: 18776971
[No Abstract] [Full Text] [Related]
2. [Secondary prevention of patients with ischaemic heart disease--the reduction of LDL cholesterol level and the regression of atherosclerosis].
Bárczi G; Merkely B
Lege Artis Med; 2007 Oct; 17(10):675-9. PubMed ID: 19227597
[TBL] [Abstract][Full Text] [Related]
3. Effects of increasing high-density lipoprotein cholesterol and decreasing low-density lipoprotein cholesterol on the incidence of first acute coronary events (from the Air Force/Texas Coronary Atherosclerosis Prevention Study).
Cui Y; Watson DJ; Girman CJ; Shapiro DR; Gotto AM; Hiserote P; Clearfield MB
Am J Cardiol; 2009 Sep; 104(6):829-34. PubMed ID: 19733719
[TBL] [Abstract][Full Text] [Related]
4. Are the ACC/AHA guidelines on the treatment of blood cholesterol a game changer? A perspective from the Canadian Cardiovascular Society Dyslipidemia Panel.
Anderson TJ; Grégoire J; Hegele RA; Couture P; Mancini GB; McPherson R; Francis GA; Poirier P; Lau DC; Grover S; Genest J; Carpentier AC; Dufour R; Gupta M; Ward R; Leiter LA; Lonn E; Ng DS; Pearson GJ; Yates GM; Stone JA; Ur E
Can J Cardiol; 2014 Apr; 30(4):377-80. PubMed ID: 24589194
[No Abstract] [Full Text] [Related]
5. Effect of lipid-lowering therapy with atorvastatin on atherosclerotic aortic plaques: a 2-year follow-up by noninvasive MRI.
Yonemura A; Momiyama Y; Fayad ZA; Ayaori M; Ohmori R; Kihara T; Tanaka N; Nakaya K; Ogura M; Taniguchi H; Kusuhara M; Nagata M; Nakamura H; Tamai S; Ohsuzu F
Eur J Cardiovasc Prev Rehabil; 2009 Apr; 16(2):222-8. PubMed ID: 19242355
[TBL] [Abstract][Full Text] [Related]
6. Cholesterol and coronary events. The current thinking.
Jones PH
Postgrad Med; 2003 Apr; 113(4 Suppl):5-14. PubMed ID: 19667618
[TBL] [Abstract][Full Text] [Related]
7. Hypercholesterolemia treatment patterns and low-density lipoprotein cholesterol monitoring in patients with a diagnosis of atherosclerosis in clinical practice.
Davidson MH; Gandhi SK; Ohsfeldt RL; Fox KM
Am J Med; 2009 Jan; 122(1 Suppl):S51-9. PubMed ID: 19110088
[TBL] [Abstract][Full Text] [Related]
8. [Aggressive statin therapy reduces the progression of atherosclerosis-- DMW15/2005].
Taut V
Dtsch Med Wochenschr; 2006 Mar; 131(9):460; author reply 460. PubMed ID: 16493575
[No Abstract] [Full Text] [Related]
9. Risk associated with statin treatment.
Kjekshus J
J Am Coll Cardiol; 2008 Jan; 51(1):91; author reply 92. PubMed ID: 18174047
[No Abstract] [Full Text] [Related]
10. C-reactive protein, anti-C-reactive protein antibodies and clinical atherosclerosis.
Rosenau BJ; Costenbader KH; Schur PH
Vasc Med; 2008 Feb; 13(1):25-8. PubMed ID: 18372435
[TBL] [Abstract][Full Text] [Related]
11. History of the cholesterol hypothesis in Britain.
Grimes DS
QJM; 2009 Jun; 102(6):436-8. PubMed ID: 19299248
[No Abstract] [Full Text] [Related]
12. ["The lower LDL cholesterol levels, the better" still valid. Negative/neutral conclusions of three studies on statins do not change the clinical practice].
Olsson AG; Nilsson PM
Lakartidningen; 2009 Mar 18-24; 106(12):854-7. PubMed ID: 19452786
[No Abstract] [Full Text] [Related]
13. Intensive lipid lowering with atorvastatin in coronary disease.
Modest GA
N Engl J Med; 2005 Jul; 353(1):93-6; author reply 93-6. PubMed ID: 16003833
[No Abstract] [Full Text] [Related]
14. Cholesterol.
Harv Mens Health Watch; 2006 Aug; 11(1):2-3. PubMed ID: 17111473
[No Abstract] [Full Text] [Related]
15. Towards consistency between guidelines and policy: lipid management--2005.
Tonkin AM
Heart Lung Circ; 2005 Dec; 14(4):237-8. PubMed ID: 16360991
[No Abstract] [Full Text] [Related]
16. Statins. Cholesterol lowering and beyond.
Mayo Clin Womens Healthsource; 2006 Jun; 10(6):1-2. PubMed ID: 16675916
[No Abstract] [Full Text] [Related]
17. The importance of recognizing and treating low levels of high-density lipoprotein cholesterol: a new era in atherosclerosis management.
Cardenas GA; Lavie CJ; Cardenas V; Milani RV; McCullough PA
Rev Cardiovasc Med; 2008; 9(4):239-58. PubMed ID: 19122582
[TBL] [Abstract][Full Text] [Related]
18. Is LDL-C passed its prime? The emerging role of non-HDL, LDL-P, and ApoB in CHD risk assessment.
Davidson MH
Arterioscler Thromb Vasc Biol; 2008 Sep; 28(9):1582-3. PubMed ID: 18716322
[No Abstract] [Full Text] [Related]
19. Clinical trials and tribulations. Cholesterol veers off script.
Couzin J
Science; 2008 Oct; 322(5899):220-3. PubMed ID: 18845747
[No Abstract] [Full Text] [Related]
20. [Significance of setting standards and guidelines for management of patients with hyperlipidemia].
Kotake H; Oikawa S
Nihon Rinsho; 2001 Mar; 59 Suppl 3():492-9. PubMed ID: 11347119
[No Abstract] [Full Text] [Related]
[Next] [New Search]
